Eton Pharmaceuticals (ETON) Return on Capital Employed Growth (3y) (2021 - 2025)
Eton Pharmaceuticals (ETON) Return on Capital Employed Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.93 Bn | 32.19 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.43 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn | 1,902.00 |
| 10 | Eton Pharmaceuticals | 1.14 Bn | 1.11 Bn | 13.10 Mn | 4,771.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,771.00 |
| Sep 30, 2025 | 4,090.00 |
| Jun 30, 2025 | 5,527.00 |
| Mar 31, 2025 | 5,053.00 |
| Dec 31, 2024 | -56.00 |
| Sep 30, 2024 | 766.00 |
| Jun 30, 2024 | -911.00 |
| Mar 31, 2024 | 5,375.00 |
| Dec 31, 2023 | 17,224.00 |
| Sep 30, 2023 | 23,795.00 |
| Jun 30, 2023 | 15,774.00 |
| Mar 31, 2023 | 9,833.00 |
| Dec 31, 2022 | 9,045.00 |
| Sep 30, 2022 | 7,800.00 |
| Jun 30, 2022 | 2,442.00 |
| Mar 31, 2022 | 1,306.00 |
| Dec 31, 2021 | 5,825.00 |